Fas ligand, tumor necrosis factor-α expression, and apoptosis during allograft rejection and tolerance

Transplantation

Volumn 66, Issue 7, 1998, Pages 887-893

  Josien, Régis ^a,b   Müschen, Markus ^a,c   Gilbert, Emmanuelle ^a   Douillard, Patrice ^a,d   Heslan, Jean Marie ^a   Soulillou, Jean Paul ^a   Cuturi, Maria Cristina ^a  

^a INSERM   (France)

^b ROCKEFELLER UNIVERSITY   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BLOOD TRANSFUSION; FAS LIGAND PROTEIN; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE TOLERANCE; MALE; MEMBRANE GLYCOPROTEINS; MYOCARDIUM; RATS; RATS, INBRED LEW; TISSUE DONORS; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0345131680     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810150-00013     Document Type: Article

References (41)

1. Walsh CM, Hayashi F, Saffran DC, Ju ST, Berke G, Clark WR. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J Immunol 1996; 156: 1436.
2. Goulmy E, Stijnen T, Groenewoud AF, et al. Renal transplant patients monitored by the cell-mediated lympholysis assay. Transplantation 1989; 48: 559.
3. Bugeon L, Cuturi M-C, Paineau J, Anegon I, Soulillou J-P. Similar levels of granzyme-A and perform mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 1993; 55: 16.
4. Dallman M, Wood K, Morris P. Specific cytotoxic T cells are found in the non-rejected kidneys of blood transfused rats. J Exp Med 1987; 165: 566.
5. Griffiths GM. The cell biology of CTL killing. Curr Opin Immunol 1995; 7: 343.
6. Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994; 1: 334.
7. Kägi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T-cell mediated cytotoxicity. Science 1994; 265: 528.
8. Koziel MD, Dudley D, Afdhal N, et al. HLA class-I restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiples epitopes and characterization of patterns of cytokine release. J Clin Invest 1995; 96: 2311.
9. Braum MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996; 183: 657.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
11. Ju S-T, Panka DJ, Cul H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444.
12. Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia-Kennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59: 621.
13. Jollow K, Sundstrom J, Gravanis M, Kanter K, Herskowitz A, Ansari A. Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy-cultured cells. Transplantation 1997; 63: 1482.
14. Bergese SD, Klenotic SM, Walkely ME, Sedmak DD, Orosz CG. Apoptosis in murine cardiac grafts. Transplantation 1997; 63: 320.
15. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity: an immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60(3): 221.
16. Seino K, Kayagaki N, Bashuda H, Okumura K, Yagita H. Contribution of Fas ligand to cardiac allograft rejection. Int Immunol 1996; 8(9): 1347.
17. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 11: 460.
18. Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death- differential intrarenal expression of Fas ligand, Fas, granzyme B and perform during acute and/or chronic rejection of human renal allografts. Transplantation 1996; 62: 1860.
19. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
20. Josien R, Pannetier C, Douillard P, et al. Graft infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor specific transfusion-induced tolerance in adult rats. Transplantation 1995; 60: 1131.
21. McWhinnie DL, Thomson J, Taylor H, et al. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 1986; 42: 352.
22. Pannetier C, Delassus S, Darche S, Saucier C, Kourilsky P. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 1993; 21: 577.
23. Govaerts A. Cellular antibodies in kidney homotransplantation. J Immunol 1960; 85: 516.
24. Sprent J, Hurd M, Shaefer M. Split tolerance in spleen chimeras. J Immunol 1995; 154: 1198.
25. Sprent J, von Boehmer H, Nabholz M. Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain. J Exp Med 1975; 142: 321.
26. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
27. Russel JH. Activation-induced death of mature T cells in the regulation of immune response. Curr Opin Immunol 1995; 7: 382.
28. MacPherson GG, Christmas SE. The role of the macrophage in cardiac allograft rejection in the rat. Immunol Rev 1984; 77: 143.
29. Ascher NL, Hoffman RA, Hanto DW, Simmons RL. Cellular basis of allograft rejection. Immunol Rev 1984; 77: 217.
30. Forbes RD, Guttmann RD, Gomersall M, Hibberd J. Leukocyte subsets in first-set rat cardiac allograft rejection: a serial immunohistologic study using monoclonal antibodies. Transplantation 1983; 36(6): 681.
31. Armstrong H, Bolton E, McMillan S, Spencer S, Bradley J. Prolonged survival of actively enhanced rat renal allograft despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med 1987; 169: 891.
32. Djeu JY, Blanchard DK, Richards AL, Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 1988; 141(11): 4047.
33. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987; 165(6): 1581.
34. Saito R, Prehn J, Zuo XJ, et al. The participation of tumor necrosis factor in the pathogenesis of lung allograft rejection in the rat. Transplantation 1993; 55(5): 967.
35. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-α and lymphotoxin enhances cardiac allograft survival in rats. Transplantation 1990; 50(2): 189.
36. Imagawa DK, Millis JM, Seu P, et al. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection. Transplantation 1991; 51(1): 57.
37. Imagawa DK, Millis JM, Olthoff KM, et al. Anti-tumor necrosis factor antibody enhances allograft survival in rats. J Surg Res 1990; 48(4): 345.
38. Maury CP, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med 1987; 166(4): 1132.
39. Stuehr D, Nathan C. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target. J Exp Med 1989; 169: 1543.
40. Moncada S, Palmer R, Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109.
41. Matsuno T, Nakagawa K, Sasaki H, et al. Apoptosis in acute tubular necrosis and acute renal allograft rejection. Transplant Proc 1994; 26: 2170.